Literature DB >> 29486392

Recent developments in intracellular protein delivery.

Yumiao Zhang1, Joachim Justad Røise2, Kunwoo Lee3, Jie Li1, Niren Murthy4.   

Abstract

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but cannot be developed into therapeutics due to challenges in delivering them into the cytoplasm. There is therefore great interest in developing strategies that can enable proteins to enter the cytoplasm of cells. In this review article we will discuss recent progress in intracellular protein therapeutics, which are focused on the following four classes of therapeutics, Firstly, vaccine development, secondly, transcription factor therapies, thirdly, gene editing and finally, cancer therapeutics. These exciting new advances raise the prospect of developing cures for several un-treatable diseases.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29486392      PMCID: PMC6082692          DOI: 10.1016/j.copbio.2018.02.009

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  41 in total

1.  In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA.

Authors:  S R Schwarze; S F Dowdy
Journal:  Trends Pharmacol Sci       Date:  2000-02       Impact factor: 14.819

2.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.

Authors:  Seung Woo Cho; Sojung Kim; Jong Min Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

3.  Intracellular delivery of artificial transcription factors fused to the protein transduction domain of HIV-1 Tat.

Authors:  Xinghui Zhao; Yunzhu Dong; Zhanzhong Zhao; Junwei Guo; Jie Liu; Peitang Huang; Dayong Dong; Hongyan Fan; Qiang Guo; Xiuxu Yang; Junjie Xu; Jianmin Li; Ling Fu; Wei Chen
Journal:  Protein Expr Purif       Date:  2013-05-03       Impact factor: 1.650

4.  Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.

Authors:  Ming Wang; John A Zuris; Fantao Meng; Holly Rees; Shuo Sun; Pu Deng; Yong Han; Xue Gao; Dimitra Pouli; Qi Wu; Irene Georgakoudi; David R Liu; Qiaobing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

5.  Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.

Authors:  Manas Mandal; Kyung-Dall Lee
Journal:  Biochim Biophys Acta       Date:  2002-06-13

6.  Intracellular processing of hapten-modified protein for MHC class I presentation: cytoplasmic delivery by pH-sensitive liposomes.

Authors:  S Martin; G Niedermann; C Leipner; K Eichmann; H U Weltzien
Journal:  Immunol Lett       Date:  1993-08       Impact factor: 3.685

7.  Enhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles.

Authors:  John T Wilson; Almar Postma; Salka Keller; Anthony J Convertine; Graeme Moad; Ezio Rizzardo; Laurence Meagher; John Chiefari; Patrick S Stayton
Journal:  AAPS J       Date:  2014-12-12       Impact factor: 4.009

8.  pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.

Authors:  John T Wilson; Salka Keller; Matthew J Manganiello; Connie Cheng; Chen-Chang Lee; Chinonso Opara; Anthony Convertine; Patrick S Stayton
Journal:  ACS Nano       Date:  2013-04-30       Impact factor: 15.881

9.  In vivo delivery of transcription factors with multifunctional oligonucleotides.

Authors:  Kunwoo Lee; Mohammad Rafi; Xiaojian Wang; Kiana Aran; Xuli Feng; Carlo Lo Sterzo; Richard Tang; Nithya Lingampalli; Hyun Jin Kim; Niren Murthy
Journal:  Nat Mater       Date:  2015-04-27       Impact factor: 43.841

10.  Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.

Authors:  Hao Yin; Chun-Qing Song; Joseph R Dorkin; Lihua J Zhu; Yingxiang Li; Qiongqiong Wu; Angela Park; Junghoon Yang; Sneha Suresh; Aizhan Bizhanova; Ankit Gupta; Mehmet F Bolukbasi; Stephen Walsh; Roman L Bogorad; Guangping Gao; Zhiping Weng; Yizhou Dong; Victor Koteliansky; Scot A Wolfe; Robert Langer; Wen Xue; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

View more
  12 in total

Review 1.  Chemoenzymatic Semisynthesis of Proteins.

Authors:  Robert E Thompson; Tom W Muir
Journal:  Chem Rev       Date:  2019-11-27       Impact factor: 60.622

Review 2.  Accessing Intracellular Targets through Nanocarrier-Mediated Cytosolic Protein Delivery.

Authors:  Ritabrita Goswami; Taewon Jeon; Harini Nagaraj; Shumei Zhai; Vincent M Rotello
Journal:  Trends Pharmacol Sci       Date:  2020-09-02       Impact factor: 14.819

Review 3.  Delivery technologies for in utero gene therapy.

Authors:  Rohan Palanki; William H Peranteau; Michael J Mitchell
Journal:  Adv Drug Deliv Rev       Date:  2020-11-09       Impact factor: 15.470

Review 4.  Tuning up Transcription Factors for Therapy.

Authors:  Attila Becskei
Journal:  Molecules       Date:  2020-04-20       Impact factor: 4.411

5.  Delivery of Mixed-Lineage Kinase Domain-Like Protein by Vapor Nanobubble Photoporation Induces Necroptotic-Like Cell Death in Tumor Cells.

Authors:  Lien Van Hoecke; Laurens Raes; Stephan Stremersch; Toon Brans; Juan C Fraire; Ria Roelandt; Wim Declercq; Peter Vandenabeele; Koen Raemdonck; Kevin Braeckmans; Xavier Saelens
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

6.  Identification of efficient prokaryotic cell-penetrating peptides with applications in bacterial biotechnology.

Authors:  Hyang-Mi Lee; Jun Ren; Kha Mong Tran; Byeong-Min Jeon; Won-Ung Park; Hyunjoo Kim; Kyung Eun Lee; Yuna Oh; Myungback Choi; Dae-Sung Kim; Dokyun Na
Journal:  Commun Biol       Date:  2021-02-15

7.  A Computational Investigation of In Vivo Cytosolic Protein Delivery for Cancer Therapy.

Authors:  Camilo Torres; Simon Dumas; Valentina Palacio-Castañeda; Stéphanie Descroix; Roland Brock; Wouter P R Verdurmen
Journal:  Pharmaceutics       Date:  2021-04-15       Impact factor: 6.321

8.  Improved transfer efficiency of supercharged 36 + GFP protein mediate nucleic acid delivery.

Authors:  Lidan Wang; Jingping Geng; Linlin Chen; Xiangli Guo; Tao Wang; Yanfen Fang; Bonn Belingon; Jiao Wu; Manman Li; Ying Zhan; Wendou Shang; Yingying Wan; Xuemei Feng; Xianghui Li; Hu Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

9.  Cell-Penetrable Peptide-Conjugated FADD Induces Apoptosis and Regulates Inflammatory Signaling in Cancer Cells.

Authors:  Kishu Ranjan; Bhargav N Waghela; Foram U Vaidya; Chandramani Pathak
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

Review 10.  RUNX2-modifying enzymes: therapeutic targets for bone diseases.

Authors:  Woo-Jin Kim; Hye-Lim Shin; Bong-Soo Kim; Hyun-Jung Kim; Hyun-Mo Ryoo
Journal:  Exp Mol Med       Date:  2020-08-13       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.